Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Sells C$49,192.00 in Stock

Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Regan Stewart sold 1,300 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of C$37.84, for a total transaction of C$49,192.00.

Regan Stewart also recently made the following trade(s):

• On Thursday, December 5th, Regan Stewart sold 2,000 shares of Jamieson Wellness stock. The shares were sold at an average price of C$37.52, for a total value of C$75,031.00.
• On Friday, November 22nd, Regan Stewart sold 6,300 shares of Jamieson Wellness stock. The shares were sold at an average price of C$35.69, for a total value of C$224,847.00.
• On Friday, November 15th, Regan Stewart sold 1,637 shares of Jamieson Wellness stock. The stock was sold at an average price of C$35.67, for a total value of C$58,384.75.

Jamieson Wellness Price Performance

JWEL stock opened at C$37.71 on Friday. The company has a current ratio of 3.21, a quick ratio of 1.08 and a debt-to-equity ratio of 92.76. The firm has a market capitalization of C$1.56 billion, a PE ratio of 43.85 and a beta of 0.63. Jamieson Wellness Inc. has a 1-year low of C$23.98 and a 1-year high of C$38.20. The business’s 50 day simple moving average is C$35.62 and its 200 day simple moving average is C$32.69.

Jamieson Wellness Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 13th. Investors of record on Friday, December 13th were issued a dividend of $0.21 per share. The ex-dividend date of this dividend was Friday, November 29th. This is a positive change from Jamieson Wellness’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a dividend yield of 2.23%. Jamieson Wellness’s payout ratio is presently 97.67%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on JWEL shares. National Bankshares boosted their price target on Jamieson Wellness from C$36.50 to C$42.00 in a research report on Monday, November 25th. TD Securities boosted their price target on Jamieson Wellness from C$40.00 to C$42.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. BMO Capital Markets boosted their price target on Jamieson Wellness from C$42.00 to C$46.00 in a research report on Thursday. Finally, Royal Bank of Canada boosted their price target on Jamieson Wellness from C$37.00 to C$38.00 in a research report on Friday, November 8th.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.